Pathological action of IL-6 in RA is determined by the stimulation of B-cell proliferation, secretion of immunoglobulins, C-reactive protein (CRP) synthesis, and differentiation of plasmatic cells and cytotoxic T-lymphocytes [179,180]. This evidence concerns the gene IL6 and rheumatoid arthritis.